How Much Do Weight Loss Shots Really Cost?

The master price table: every shot, every channel

Everything on the US market for injectable weight loss, priced per month:

All figures are 2026 monthly prices. Compounded options have no list price because they are pharmacy-prepared for individual prescriptions rather than sold as branded products.

Why identical molecules span a 13x price range

The range is not about the drug in the syringe. Compounded semaglutide at $99 and Wegovy at $1,349 deliver the same active molecule. The spread comes from three layers stacked on top of the ingredient: the brand and its FDA-approved finished-product status, the delivery device, since pens cost more to make than vials, and the sales channel, because retail list prices exist mostly as a starting point for insurance negotiations rather than a price anyone is meant to pay in cash.

Manufacturers effectively admitted this by launching their own discount channels. When Novo Nordisk sells the same $1,349 pen for $499 direct, and Lilly sells $1,086 tirzepatide for $349 in vial form, the real cash market has moved to the $99–$499 band. Full molecule-level breakdowns: semaglutide pricing and tirzepatide pricing.

The range also explains why quoted "average prices" for weight loss shots are nearly useless: an average of $99 and $1,349 describes nobody. The distribution is bimodal, a large cash-pay cluster in the $99–$499 band and an insured cluster at $25–$50 copays, with list prices existing mostly on paper. A headline citing a four-figure monthly cost is quoting the sticker almost no informed buyer pays.

Which price bracket you will actually land in

Most people end up in one of four brackets, determined by two questions: does your insurance cover weight loss medication, and do you want the brand product or accept compounded?

• $25–$50 a month: insured, plan covers weight loss drugs, prior authorization approved. The best deal in the market, but the rarest.
• $99–$299 a month: cash payer, compounded semaglutide via telehealth. The volume bracket in 2026.
• $199–$499 a month: cash payer wanting tirzepatide, compounded or LillyDirect vials, or brand semaglutide via NovoCare at $499.
• $998–$1,349 a month: retail list price. Essentially a bracket for people who have not checked the direct programs.

Eligibility gates every bracket equally: the standard criteria are a BMI of 30 or higher, or 27 with a weight-related condition such as hypertension or sleep apnea, evaluated by a licensed provider. The eligibility assessment takes about two minutes if you have not confirmed where you stand.

Price against results: what each dollar buys

The two molecules do not perform identically, which matters when comparing monthly prices. In clinical trials, semaglutide averaged about 15% body weight loss over 68 weeks (STEP-1), while tirzepatide averaged 20.9% over 72 weeks (SURMOUNT-1). The SURMOUNT-5 head-to-head made it direct: 20.2% for tirzepatide against 13.7% for semaglutide.

So tirzepatide buys roughly six extra percentage points of average weight loss, at a cash floor about $100 a month higher, $199 versus $99 compounded, and a similar brand-channel premium. For a 220 lb starting weight, those trial averages translate to roughly 30 lb versus 44 lb over the trial periods, individual results varying widely. The full head-to-head comparison weighs the trade-off in detail, including side effect profiles.

Whichever bracket you land in, three side costs recur across channels and belong in the comparison. Clinical oversight: bundled into most telehealth prices, separate for direct-pharmacy routes, where uninsured visits can add $100–$200 a year. Supplies: vial formats need syringes and sharps disposal; pens do not. And continuity logistics: programs differ on shipping cadence and refill authorizations, and an interrupted week is a real cost in a treatment built on weekly consistency. Two offers $30 apart on sticker can swap places once these are added, so the number to compare is the all-in cost of twelve uninterrupted months.

Five moves that lower the bill

In descending order of impact:

• Verify coverage before paying cash. Ten minutes with your formulary documents can be worth $5,000 a year. Our insurance guide covers the prior authorization process step by step.
• Never pay retail list. The manufacturer direct programs, $499 NovoCare and $349–$499 LillyDirect, exist precisely so cash payers avoid it.
• Price compounded honestly. $99–$449 depending on molecule and dose, from licensed pharmacies with prescriber oversight, under post-shortage rules that favor established programs.
• Use HSA/FSA dollars. Prescribed GLP-1 medications are eligible, an effective 20–35% discount for most tax brackets.
• Budget annually, not monthly. Trials measured results at 68–72 weeks; a plan you can sustain at month twelve beats a cheaper one you abandon at month three.

To see current program pricing across the cash-pay options, compare weight loss shot plans here.